47 Many reports have subsequently been published, and a consensus statement was published asserting that genotype 1b is more resistant to IFN than genotype 2 and 3 and

recommending combination therapy with ribavirin.48 With the advent of peg-IFN plus ribavirin combination therapy, the eradication rate of the virus has improved. The response rate of the combination therapy is also dependent on HCV genotype (Table 1), as reflected in three consensus statements published in different geographic areas.69–71 Specific nucleotide and amino acid substitutions have been reported to be correlated with the effect of both IFN therapy and peg-IFN plus ribavirin combination therapy. Enomoto et al. first noted that outcome of IFN therapy is related to the total number of amino Daporinad mw acid substitutions in a 40 amino acid stretch

selleck inhibitor of the NS5A region.72,73 They designated this region the interferon sensitivity determining region (ISDR). Following this discovery, several other regions were also reported to correlate with the effect of IFN or peg-IFN plus ribavirin combination therapy. Corresponding amino acid sequences that have been reported so far are listed in Table 2. Recently, Enomoto et al. compared 88 full-length genotype 1b nucleotide sequences obtained from patients treated with peg-IFN plus ribavirin combination therapy and found that only core and ISDR amino acid substitutions are predictive of early response to therapy.108 Substitution of core protein amino acid 70 is of particular interest, not only as a predictor of effect of peg-IFN plus ribavirin combination therapy, but also because of the curious interactions between viral and host proteins as discussed below. Recently, an association between common genetic variation in the human

IL28B locus and the effect of peg-interferon and ribavirin therapy was found.135–138 The single nucleotide polymorphisms (SNPs) in the IL28B locus that are associated with SVR following combination therapy (rs8099917T and rs12979860 C) have higher allele frequencies in Asian and Caucasian populations than in African populations, in which the response to IFN is known to be relatively poorer than other ethnic groups. rs12979860 medchemexpress has also been reported to be associated with spontaneous eradication of HCV.139 Interestingly, we found that amino acid substitutions in the core region of HCV are strongly associated with IL28B SNP genotype. As shown in Fig. 4, the T allele of SNP rs8099917 within the IL28B locus is associated with core amino acid 70 arginine, which is associated with favorable response to peg-IFN plus ribavirin combination therapy.130,131 This association of human genetic variation and viral amino acid substitutions is particularly interesting. The viral strain that is relatively more sensitive to the combination therapy is more prevalent in patients that have the SNP genotype associated with a higher eradication rate of the virus by combination therapy or spontaneous elimination.